2026-04-25T05:49:25Z https://www.pub.unibl.org/oai

oai:pub.unibl.org:66639 2026-02-13T04:43:17Z

Academic Article text Saffety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study. Amit Bar Or, Michal Dufek, Hrvoje Budincevic, Jelena Drulovic, Mario Habek, Le H Huan, Martin SVeber, Piia Thomas, Сања Гргић, Spomenka Kidemet Piskac Amit Bar Or Unknown Michal Dufek Unknown Hrvoje Budincevic Unknown Jelena Drulovic Unknown Mario Habek Unknown Le H Huan Unknown Martin SVeber Unknown Piia Thomas Unknown Сања Гргић Unknown Spomenka Kidemet Piskac Unknown not applicable 2025-08 2025-08 2025-08 location unknown 66639 item oai:pub.unibl.org:66639